Form CORRESP - Correspondence:
SEC Accession No. 0001140361-20-011394
Filing Date
2020-05-12
Accepted
2020-05-12 13:18:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 7248
  Complete submission text file 0001140361-20-011394.txt   8177
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)